Evaluation of efficacy and safety of Dabigaran in patients with catheter ablation for atrial fibrillation.
Not Applicable
Recruiting
- Conditions
- Atrial fibrillation
- Registration Number
- JPRN-UMIN000011223
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with chronic atrial fibrillation, valvular heart diseases, severe renal dysfunction, history of allergy of this drug, bleeding tendency, high risk of bleeding, subdural catheter, and antithrombotic drugs.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cerebral bleeding and stroke, systematic embolism, bleeding complication
- Secondary Outcome Measures
Name Time Method Abnormal finding in blood test